Benzinga | Oct 20, 2021 07:17AM EDT

AVROBIO To Present At The Jefferies Virtual Gene Therapy/Editing Summit

AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that members of its senior management team will present at the Jefferies Virtual Gene Therapy/Editing Summit at 10:30 a.m. ET on Thursday, Oct. 28, 2021.

A live webcast of the presentation can be accessed under "Events and Presentations" in the Investors & Media section of the Company's website at www.avrobio.com. An archived webcast recording of the presentation will also be available on the website.